Thomas H Brannagan 3rd
Overview
Explore the profile of Thomas H Brannagan 3rd including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
2493
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Monohan E, Brannagan 3rd T
Semin Neurol
. 2024 Oct;
45(1):122-131.
PMID: 39419067
Immune-mediated neuropathies encompass a range of neurological disorders, including chronic inflammatory demyelinating polyradiculoneuropathy, Guillain-Barré syndrome, multifocal motor neuropathy, autoimmune autonomic neuropathies, and paranodal nodopathies. Recognizing clinical patterns is key to...
2.
Latov N, Brannagan 3rd T, W Sander H, de Assis Aquino Gondim F
Arq Neuropsiquiatr
. 2024 Feb;
82(6):1-7.
PMID: 38325389
Background: Patients with anti-MAG neuropathy present with distal demyelinating polyneuropathy, IgM monoclonal gammopathy, and elevated titers of anti-MAG antibodies. Objective: This paper reviews what is known about the clinical presentation,...
3.
Karam C, Mauermann M, Gonzalez-Duarte A, Kaku M, Ajroud-Driss S, Brannagan 3rd T, et al.
Muscle Nerve
. 2024 Jan;
69(3):273-287.
PMID: 38174864
Hereditary transthyretin (ATTRv; v for variant) amyloidosis is a rare, multisystem, progressive, and fatal disease in which polyneuropathy is a cardinal manifestation. Due to a lack of United States (US)-specific...
4.
Miranda C, Brannagan 3rd T
Handb Clin Neurol
. 2023 Aug;
195:619-633.
PMID: 37562890
Autoimmune neuropathy may present acutely or with a more progressive and/or relapsing and remitting course. Acute inflammatory neuropathy or Guillain-Barré syndrome (GBS) has variable presentations but by far the most...
5.
Tavee J, Brannagan 3rd T, Lenihan M, Muppidi S, Kellermeyer L, D Donofrio P
Muscle Nerve
. 2023 Jul;
68(4):356-374.
PMID: 37432872
Intravenous immune globulin (IVIG) is an immune-modulating biologic therapy that is increasingly being used in neuromuscular disorders despite the paucity of high-quality evidence for various specific diseases. To address this,...
6.
Bril V, Hadden R, Brannagan 3rd T, Bar M, Chroni E, Rejdak K, et al.
J Peripher Nerv Syst
. 2023 Jun;
28(3):436-449.
PMID: 37314318
Background And Aims: ADVANCE-CIDP 1 evaluated facilitated subcutaneous immunoglobulin (fSCIG; human immunoglobulin G 10% with recombinant human hyaluronidase) efficacy and safety in preventing chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) relapse. Methods:...
7.
Carberry N, Yu S, Fayerman R, Dugue R, Miller M, Tanji K, et al.
Neurohospitalist
. 2022 Dec;
13(1):90-95.
PMID: 36531853
A 31-year-old woman with transthyretin (TTR) amyloidosis secondary to a Thr60Ala mutation developed recurrent stroke-like episodes with fluctuating mental status. Evaluation for stroke and seizures was unrevealing. She was found...
8.
Brannagan 3rd T, Berk J, Gillmore J, Maurer M, Waddington-Cruz M, Fontana M, et al.
J Peripher Nerv Syst
. 2022 Nov;
27(4):228-237.
PMID: 36345805
Transthyretin-mediated amyloidosis (ATTR) is a rare, under-recognized, progressively debilitating, fatal disease caused by the aggregation and extracellular deposition of amyloid transthyretin (TTR) fibrils in multiple organs and tissues throughout the...
9.
Schelke M, Barcavage S, Lampshire E, Brannagan 3rd T
Muscle Nerve
. 2022 Aug;
66(4):E21-E23.
PMID: 35934893
No abstract available.
10.
Thomas F, Brannagan 3rd T, Butterfield R, Desai U, Habib A, Herrmann D, et al.
Neurology
. 2022 May;
98(23):e2356-e2367.
PMID: 35545446
Background And Objectives: The goal of this work was to determine whether locally acting ACE-083 is safe and well tolerated and increases muscle volume, motor function, and quality of life...